In Conversation

"We are intimately familiar with the culture of safety, the quality, the specific demands and the timelines that FDI clients need. This is particularly relevant to…

"In terms of life science, we have begun to invest in niche products, for example nuclear medicine. Not many companies are involved in radioactive products, and…

"The medtech industry, as a group of people, are at a higher pitch in terms of the degree of change they have to go through."

"Working with the HSE teams in hospitals and Community Health Organizations gives us the opportunity to help patients through their journey with a chronic condition, which…

"Generally speaking, we have a simple three-lens approach to asset acquisition. First is the strategic fit of the capability, second is the financial return and third…

"Fundamentally, we have excellent products in our area of expertise. They are very well-accepted, and our brand is also widely respected in Ireland."

"The questions some of our clients are asking at the moment are around the next phase of growth and how to control costs"

"Our published turnover in Ireland for 2015 in the mechanical, electrical and fire protection sectors confirms that we are a third bigger than our nearest competitor."

"Ireland is one of the highest performing economies within the EU, something which is a significant draw for life sciences companies seeking to tap into our…

"One thing that has excited us is how certain large innovative companies are willing to help smaller companies, provided they see some robust proof of concept…

"A big driver for Ireland and the industry itself is inventory management. The days of being a merely transactional company, where someone places a PO, you…

"Providing information to help patients take control of their health and be more empowered is very important for MSD."

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here